ADURO BIOTECH HOLDINGS EUROPE B V has a total of 58 patent applications. It increased the IP activity by 7.0%. Its first patent ever was published in 2010. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BIOSCEPTRE INT LTD, MUELLER-HERMELINK HANS KONRAD and FORERUNNER PHARMA RES CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Australia | 7 | |
#3 | EPO (European Patent Office) | 6 | |
#4 | Netherlands | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 4 | |
#6 | Canada | 3 | |
#7 | Taiwan | 3 | |
#8 | Argentina | 2 | |
#9 | Brazil | 2 | |
#10 | China | 2 | |
#11 | Hong Kong | 2 | |
#12 | Israel | 2 | |
#13 | Republic of Korea | 2 | |
#14 | Mexico | 2 | |
#15 | Singapore | 2 | |
#16 | South Africa | 2 | |
#17 | Hungary | 1 | |
#18 | Slovenia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Van Eenennaam Hans | 44 |
#2 | Van Elsas Andrea | 37 |
#3 | Hulsik David Lutje | 24 |
#4 | Medema Jan Paul | 18 |
#5 | Vink Paul | 16 |
#6 | Voets Erik | 10 |
#7 | Kreijtz Joost | 10 |
#8 | Andrea Van Elsas | 10 |
#9 | Hans Van Eenennaam | 9 |
#10 | David Lutje Hulsik | 7 |
Publication | Filing date | Title |
---|---|---|
WO2020144535A1 | Methods and compositions for treatment of multiple myeloma | |
CN110650976A | anti-SIRP alpha antibodies | |
NL2018708B1 | ANTI-SIRPα ANTIBODIES | |
NL2017270B1 | New anti-hCTLA-4 antibodies | |
NL2017267B1 | Anti-pd-1 antibodies | |
AU2015202353A1 | Agonistic antibody to CD27 | |
AU2015201974A1 | Antibodies against a proliferating inducing ligand (APRIL) | |
NL2014108A | Altered april binding antibodies. | |
AU2011275749A1 | Agonistic antibody to CD27 | |
CA2919467A1 | Antibodies against a proliferating inducing ligand (april) |